PATENT CLAIM ANALYSIS

Application Number: 15920285
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-09
Patent Classification: ["435", "188000"]

Abstract:
Disclosed herein are ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP) complexes and synthetic molecules that interact with an ENPP protein. In some embodiments, also disclosed herein are modified ENPP polypeptides in complex with a synthetic molecule described herein.

Claim (Index 14):
The ENPP-molecule complex of  claim 12 , wherein R 7  is hydrogen, halogen, \u2014CN, \u2014OR 11 , \u2014NR 11 R 12 , \u2014NR 11 C(\u2550O)R 10 , \u2014C(\u2550O)NR 11 R 12 , optionally substituted C 1 -C 6  alkyl, optionally substituted C 1 -C 6  heteroalkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, or optionally substituted heteroaryl; provided that R 7  is not substituted imidazolyl.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.25806
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13059195', '11687565', '14679866', '12567258', '13093729']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6827511205134732
- 35 USC 102 Novelty (BERT): 0.5259879182985088
- Combined Prediction Score: 0.6670748002919767
- Mean Citation Score: 344.90997600000014
- Max Citation Score: 351.1761
- Similarity Product: 245.9202006399751

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test